Sort
51,570 grants matching “autoimmune disease”
Extracellular Vesicle-mediated islet immune cross talk in Type 1 Diabetes pathogenesis
$751,132Helena Kristiina Reijonen · Beckman Research Institute/City Of Hope · R01 · FY2024 · DK
Extracellular Vesicle-mediated islet immune cross talk in Type 1 Diabetes pathogenesis
$751,132Helena Kristiina Reijonen · Beckman Research Institute/City Of Hope · R01 · FY2023 · DK
Alternative RNA splicing events contribute to the onset of islet dysfunction in T1D
$750,874Lori Sussel · University Of Colorado Denver · U01 · FY2020 · DK
Cis-Regulatory Circuits for ILC Function and Plasticity
$750,844Marco Colonna · Washington University · R01 · FY2025 · AI
Elucidating the immunology of autoantibody formation and function in COVID-19
$750,712Angela J Rogers · Stanford University · R01 · FY2023 · AI
Beta-2 adrenergic signaling in immune homeostasis and reconstitution
$750,705Xuefang Cao · University Of Maryland Baltimore · R01 · FY2024 · HL
Role of T cells in tau-mediated neurodegeneration
$750,628David M Holtzman · Washington University · R01 · FY2024 · AG
Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis
$750,550V Michael Holers · University Of Colorado Denver · P30 · FY2023 · AR
Robust allograft tolerance in non-human primates
$750,495Megan Sykes · Columbia University Health Sciences · R01 · FY2017 · OD
THE TEDDY STUDY - COLORADO CLINICAL CENTER
$750,433Marian J. Rewers · University Of Colorado Denver · U01 · FY2020 · DK
Molecular and single-cell immunology of myalgic encephalomyelitis/chronic fatigue syndrome
$750,389Ronald Wayne Davis · Stanford University · R01 · FY2020 · AI
Regulatory T Cells in Allogeneic Transplantation
$750,258Robert S Negrin · Stanford University · RC2 · FY2010 · HL
The landscape of HLA mediated variation in health and immunity
$750,148Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2021 · AI
Stanford Technology Accelerating Medicines Partnership Center
$750,001William H Robinson · Stanford University · UH2 · FY2014 · AR
Molecular Pathways in Treatment Response and Flare in RA
$750,001Vivian P Bykerk · Hospital For Special Surgery · UH2 · FY2015 · AR
A pro-resolution lipid mediator for treatment of rheumatoid arthritis
$750,000Prakash Jagtap · Radikal Therapeutics, Inc. · R44 · FY2016 · AR
Web Software for Drug Targeting Signaling Networks in Primary Cell Subsets
$750,000Nikesh Kotecha · Cytobank, Inc. · R44 · FY2014 · GM
Web Software for Drug Targeting Signaling Networks in Primary Cell Subsets
$750,000David Craford · Cytobank, Inc. · R44 · FY2015 · GM
A pro-resolution lipid mediator for treatment of rheumatoid arthritis
$750,000Prakash Jagtap · Radikal Therapeutics, Inc. · R44 · FY2017 · AR
Complex 3-Dimensional in vitro Human Skin Tissue Models for Scleroderma
$749,999Yolanda Camille Nesbeth · Celdara Medical, Llc · R44 · FY2018 · AR
An Automated Device for High Yield Mesenchymal Stem Cell Extraction
$749,990Lotien Richard Huang · Cg Scientific, Inc. · R44 · FY2018 · EB
An Automated Device for High Yield Mesenchymal Stem Cell Extraction
$749,990Lotien Richard Huang · Cg Scientific, Inc. · R44 · FY2019 · EB
Cellular Immunotherapy for Systemic Sclerosis
$749,904Joana M Murad · Celdara Medical, Llc · R44 · FY2019 · AR
Rapid Analysis of Single T Cell Immunity Signatures in Tuberculosis
$749,849Yuri Bushkin · Rbhs-New Jersey Medical School · R01 · FY2015 · AI
Rapid Analysis of Single T Cell Immunity Signatures in Tuberculosis
$749,849Yuri Bushkin · Rbhs-New Jersey Medical School · R01 · FY2014 · AI